Kaitai Capital

Kaitai Capital is a Chinese venture capital firm that appears to invest across early-stage technology and consumer companies, though elsewhere's corpus does not contain a direct profile of the fund itself. The available material shows it participating in deals as both a lead and co-investor: it led a Series A in open-source data infrastructure company White Whale Open Source , co-invested in AI startup Xinchen AI alongside Baidu Ventures and others , backed radiopharmaceutical developer Bivision Pharmaceuticals (晶核生物) in its angel round , and made an angel investment in online cereal brand WANGBAOBAO . These deals span 2019 to at least 2023, with sectors including AI, biotech, open-source infrastructure, and consumer brands. The fund is referenced as a "老股东" (existing shareholder) in the 2022 Bivision Pharmaceuticals deal, suggesting it had invested in an earlier round as well. elsewhere's corpus does not cover Kaitai Capital's founding date, fund size, or full team composition.